Even in eosinophilic granulomatosis with polyangiitis (EGPA), not all manifestations of eosinophilic inflammation respond equally to anti–interleukin-5 (IL-5) therapy. The gene discussed is IL5; the disease is eosinophilic granulomatosis with polyangiitis.